Arcus Biosciences, Inc. (RCUS) › Operating IncomeArcus Biosciences, Inc. (RCUS) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$18.18M2017: -$53.44M2018: -$54.86M2019: -$88.71M2020: -$124.00M2021: $54.00M2022: -$280.00M2023: -$340.00M2024: -$330.00M2025: -$386.00M-$386.00M2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$386.00M-17.0%2024-$330.00M+2.9%2023-$340.00M-21.4%2022-$280.00M-618.5%2021$54.00M+143.5%2020-$124.00M-39.8%2019-$88.71M-61.7%2018-$54.86M-2.7%2017-$53.44M-193.9%2016-$18.18M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share